razoxane has been researched along with Hemangiosarcoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eiter, H; Ginestet, A; Hackl, A; Lukas, P; Pakisch, B; Pokrajac, B; Pötter, R; Rhomberg, W; Wink, A | 1 |
Breitfellner, G; Eiter, H; Fritzsche, H; Gruber-Mösenbacher, U; Rhomberg, W | 1 |
Grass, M; Rhomberg, W | 1 |
1 review(s) available for razoxane and Hemangiosarcoma
Article | Year |
---|---|
[Angiosarcoma of the right atrium: local control via low radiation doses and razoxane. A case report].
Topics: Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Fatal Outcome; Heart Atria; Heart Neoplasms; Hemangiosarcoma; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Radiotherapy Dosage; Radiotherapy, Adjuvant; Razoxane | 1999 |
1 trial(s) available for razoxane and Hemangiosarcoma
Article | Year |
---|---|
Treatment of vascular soft tissue sarcomas with razoxane, vindesine, and radiation.
Topics: Aged; Drug Administration Schedule; Female; Hemangiopericytoma; Hemangiosarcoma; Humans; Male; Middle Aged; Radiation-Sensitizing Agents; Radiotherapy Dosage; Razoxane; Vindesine | 2009 |
1 other study(ies) available for razoxane and Hemangiosarcoma
Article | Year |
---|---|
[Prognosis and epidemiology of malignant hemangioendotheliomas of the thyroid gland].
Topics: Aged; Austria; Combined Modality Therapy; Female; Hemangiosarcoma; Humans; Incidence; Male; Middle Aged; Prognosis; Radiotherapy Dosage; Razoxane; Thyroid Neoplasms | 1993 |